ArticleF1000Research2022
Promoting access of hydroxyurea to sickle cell disease individuals: Time to make it an essential medicine.
Manase Kilonzi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it